HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

3',5-Dichlorosalicylanilide

HCID 20196
NotesReactions
Basic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
22203-98-1
Standard SMILES
O=C(Nc1cccc(Cl)c1)c1cc(Cl)ccc1O
InChIKey
NXDGLRGDIKDWIF-UHFFFAOYSA-N
Molecular formula
C13H9Cl2NO2
Average molar mass
282.12 g/mol
Monoisotopic mass
281.0010339

Names & identifiers

Preferred name
3',5-Dichlorosalicylanilide
IUPAC
5-chloro-N-(3-chlorophenyl)-2-hydroxybenzamide
English name
5-chloro-N-(3-chlorophenyl)-2-hydroxy-benzamide
Molecular formula
C13H9Cl2NO2
Molecular weight
282.12

Names & synonyms

22203-98-13',5-DICHLOROSALICYLANILIDEL9HQV0JFNHUNII-L9HQV0JFNHBenzamide, 5-chloro-N-(3-chlorophenyl)-2-hydroxy-NSC-50643DTXSID801767525,3'-DICHLOROSALICYLANILIDENSC 50643SALICYLANILIDE, 3',5-DICHLORO-RefChem:90267DTXCID4099243
Show more names
SARS-CoV-2-IN-14, 10 mM in DMSO
5-chloro-N-(3-chlorophenyl)-2-hydroxybenzamideSARS-CoV-2-IN-14Benzamide,5-chloro-N-(3-chlorophenyl)-2-hydroxy-5-CHLORO-N-(3-CHLOROPHENYL)-2-HYDROXY-BENZAMIDECHEMBL2088011NSC50643orb1689487SCHEMBL11932152

Database identifiers

CAS
22203-98-1
PubChem CID
20196
DTXSID
DTXSID80176752
ChEMBL
CHEMBL2088011
UNII
L9HQV0JFNH
Nikkaji
J2.331.052J

Properties

Computed structural properties

XLogP
4.5
Topological polar surface area
49.3 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
2
Rotatable bonds
2
Heavy atoms
18
Formal charge
0
Complexity
301

Physicochemical properties

form
Solid
color
White to off-white
FDA UNII
9 HQV0JFNH · L9HQV0JFNH

Chemistry & industry

Applications · 1 item

UsesSARS-CoV-2-IN-14 (compound 6) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.39 μM. SARS-CoV-2-IN-14 is a niclosamide analogue. SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally[1].

Suppliers17 total

上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
銳迪國際科技有限公司18024082417 · [email protected]
武汉泰凯塞科技有限公司027-86697669 13986148687 · [email protected]
武汉凯美克化学科技有限公司027-87342388 18086026008 · [email protected]
Shenzhen Excellent Biotech Co., Ltd.13480692018 · [email protected]
上海昶衍化工科技有限公司021-20242659 18930833303 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海寰川实业有限公司021-61478794 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
浙江珲达生物科技有限公司0571-89903022 18679456698 · [email protected]
湖北创联康成药物化学有限公司027-65388397 18164111589 · [email protected]

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
上海源叶生物科技有限公司18916372613 · [email protected]
天津凯利奇生物科技有限公司15076683720 · [email protected]
常州千艾生物科技有限公司051915240519135 13961152745 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
合肥钼凯医药科技有限公司18001872185; 18001872185 · [email protected]